Showing 6861-6870 of 18626 results for "".
Can We Rely on Warm Weather to Stop the Spread of COVID-19?
https://reachmd.com/programs/covid-19-frontlines/can-we-rely-on-warm-weather-to-stop-the-spread-of-covid-19/11627/Conventional wisdom tells us that warm weather will slow the spread of contagion. But based on a recent report, that may not be the case with COVID-19.Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
https://evolvemeded.com/specialty/optometry/adcs-pretreatment-assessment-2421/32361/Learn more about pretreatment assessment and ocular toxicity management for patients treated with antibody drug conjugates.The HPV Data Is In — What Do the Newest Updates in Screening Mean For Your Patients?
https://reachmd.com/clinical-practice/obgyn-and-womens-health/the-hpv-data-is-in-what-do-the-newest-updates-in-screening-mean-for-your-patients/10075/This previously-aired broadcast provides a brief overview of the newest HPV screening recommendations and answers the audience’s pressing questions.Establishing Best Practices for Collaborative Care for Patients with ASCVD Between Academic and Rural Providers
https://reachmd.com/programs/cme/establishing-best-practices-for-collaborative-care-for-patients-with-ascvd-between-academic-and-rural-providers/29824/Bridge the gap! Experts address ASCVD risks in rural areas and provide their best practices to create healthier, more connected communities.Biomimicry
https://modernaesthetics.com/ma-issues-index/july-august-2025/biomimicry-why-it-matters-for-dermal-fillers/36656/Why it matters for dermal fillersBuilding Bridges, Closing Gaps in NASH Care: The Pivotal Role of Gastroenterologists
https://reachmd.com/programs/cme/building-bridges-closing-gaps-in-nash-care-the-pivotal-role-of-gastroenterologists/15671/Are you up to date on the NAFLD clinical care pathway to provide optimal treatment for your patients?Axatilimab for Chronic Graft-Versus-Host Disease: A Look at a Phase 3 Trial
https://reachmd.com/programs/project-oncology/axatilimab-for-chronic-graft-versus-host-disease-a-look-at-a-phase-3-trial/36312/Chronic graft-versus-host disease (cGVHD) is a serious condition that causes highly debilitating symptoms in patients who’ve received allogeneic hematopoietic stem cell transplantation. That’s why, as of June 2025, a phase 3 trial is currently examining the efficacy and safety of axatilimab comparedFirst Results From Cohort 4 of the SunRISe-1 Trial
https://reachmd.com/clinical-practice/oncology-hematology/first-results-from-cohort-4-of-the-sunrise-1-trial/33213/Dr. Neal Shore discusses new data from SunRISe-1 on TAR-200 monotherapy in patients with BCG-unresponsive papillary disease-only high-risk NMIBC.The Promise and Future of Gene Therapy
https://reachmd.com/programs/cme/the-promise-and-future-of-gene-therapy/35550/Don’t miss this opportunity to learn the latest in new and emerging hemophilia therapies and optimize your patient care strategies.Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
https://reachmd.com/programs/cme/evaluating-novel-factor-replacement-strategies-extended-and-ultra-half-life-factors-and-factor-mimetics/35548/Don’t miss this opportunity to learn the latest in new and emerging hemophilia therapies and optimize your patient care strategies.